Tyson J, Ellis D, Fairbrother U, King R H, Muntoni F, Jacobs J, Malcolm S, Harding A E, Thomas P K
Molecular Genetics Unit, Institute of Child Health, London, UK.
Brain. 1997 Jan;120 ( Pt 1):47-63. doi: 10.1093/brain/120.1.47.
Nine cases are described of a demyelinating peripheral neuropathy that had an onset in infancy. The clinical features conformed to those of type III hereditary motor and sensory neuropathy or Dejerine-Sottas disease. All showed a severe neurological deficit and had profoundly reduced nerve conduction velocities. Amongst these cases we identified four novel point mutations in the peripheral myelin protein 22 (PMP22) gene. These were Ser72Trp, Ser76lle and Leu80Pro. The Ser72Trp mutation was dominantly inherited by a mother and son, both severely affected. Two novel mutations in the gene for P0 myelin protein were also detected. These were Ile134Thr in exon 3, and a complex rearrangement in exon 4. The remaining three patients had presumed autosomal recessive inheritance. In these, no abnormality for the PMP22 and P0 genes was detected and a mutation at another locus or loci seems probable. On nerve biopsy the final two cases were shown to be examples of hereditary neuropathy with focally folded myelin sheaths. One showed both bulbar and diaphragmatic involvement. It is concluded that hereditary demyelinating neuropathy of infancy is genetically heterogeneous. Mutational screening for the PMP22 and P0 genes and nerve biopsy are therefore merited in patients with a childhood demyelinating neuropathy that is more severe than usual and in whom a chromosome 17 duplication is not present.
本文描述了9例婴儿期起病的脱髓鞘性周围神经病。临床特征符合III型遗传性运动和感觉神经病或Dejerine-Sottas病。所有病例均有严重的神经功能缺损,神经传导速度显著降低。在这些病例中,我们在外周髓磷脂蛋白22(PMP22)基因中鉴定出4个新的点突变。分别为Ser72Trp、Ser76lle和Leu80Pro。Ser72Trp突变由一位母亲和儿子显性遗传,两人均严重受累。还检测到P0髓磷脂蛋白基因的2个新突变。分别为外显子3中的Ile134Thr和外显子4中的复杂重排。其余3例患者推测为常染色体隐性遗传。在这些病例中,未检测到PMP22和P0基因异常,可能存在其他一个或多个位点的突变。神经活检显示最后2例为遗传性周围神经病伴局灶性髓鞘折叠。其中1例同时累及延髓和膈肌。结论是婴儿期遗传性脱髓鞘性周围神经病在遗传上具有异质性。因此,对于儿童期起病、病情比通常严重且不存在17号染色体重复的脱髓鞘性周围神经病患者,对PMP22和P0基因进行突变筛查以及进行神经活检是有必要的。